A detailed history of Ifp Advisors, Inc transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 35 shares of HRTX stock, worth $59. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Holding current value
$59
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$1.06 - $2.12 $37 - $74
35 New
35 $0
Q3 2023

Oct 12, 2023

BUY
$0.97 - $1.8 $262 - $487
271 New
271 $0
Q3 2021

Oct 06, 2021

SELL
$10.13 - $15.0 $0 - $0
0 Closed
0 $0
Q2 2021

Jul 13, 2021

SELL
$13.27 - $18.48 $2,654 - $3,696
-200 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$14.49 - $20.72 $2,289 - $3,273
158 Added 376.19%
200 $3,000
Q4 2020

Jan 25, 2021

BUY
$14.61 - $22.14 $613 - $929
42 New
42 $1,000
Q3 2020

Oct 29, 2020

BUY
$13.67 - $17.77 $0 - $0
0 New
0 $0
Q2 2020

Aug 05, 2020

BUY
$10.89 - $21.47 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

BUY
$10.23 - $24.56 $0 - $0
0 New
0 $0
Q4 2019

Jan 17, 2020

BUY
$17.42 - $26.61 $0 - $0
0 New
0 $0
Q3 2019

Nov 07, 2019

BUY
$16.36 - $21.39 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

SELL
$23.15 - $28.34 $324 - $396
-14 Closed
0 $0
Q4 2018

Jan 23, 2019

SELL
$22.03 - $32.01 $4,956 - $7,202
-225 Reduced 94.14%
14 $0
Q3 2018

Oct 25, 2018

BUY
$30.0 - $40.85 $750 - $1,021
25 Added 11.68%
239 $0
Q2 2018

Aug 07, 2018

BUY
$26.4 - $42.0 $5,280 - $8,400
200 Added 1428.57%
214 $0
Q1 2018

May 09, 2018

BUY
$18.43 - $28.8 $239 - $374
13 Added 1300.0%
14 $0
Q4 2016

Jun 03, 2019

SELL
N/A
-11 Reduced 91.67%
1 $0
Q2 2016

Jun 03, 2019

BUY
N/A
12
12 $0

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $201M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.